Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Determining the acceptability of a novel One Health vaccine for Rift Valley Fever prior to phase II/III clinical trials in Uganda.

Autor: Bowmer A; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda., Ssembatya J; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda., Okot M; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda., Bagyenyi R; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda., Rubanga SV; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda., Kalema-Zikusoka G; London School of Hygiene and Tropical Medicine | Conservation Through Public Health | Uganda Virus Research Institute, Uganda.

Publikováno v: One health (Amsterdam, Netherlands) [One Health] 2022 Dec 06; Vol. 16, pp. 100470. Date of Electronic Publication: 2022 Dec 06 (Print Publication: 2023).